Author:
Kikuchi Daisuke,Obara Taku,Suzuki Hiroyuki,Konno Taisuke,Okada Kouji,Nakamura Hitoshi,Murai Yuriko
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235–481.
2. Kikuchi D, Obara T, Miura R, Suzuki N, Hirakawa H, Josaka R, et al. Antihypertensive drug prescription trends for pregnant women with hypertension in acute hospitals in Japan. Hypertens Res. 2022;45:1441–6.
3. Ministry of Health, Labour and Welfare. Revision of precautions for use of two calcium channel blockers (amlodipine besylate and nifedipine) (in Japanese), 2022. https://www.mhlw.go.jp/content/11120000/001015135.pdf. Accessed 12 April 2024.
4. Japan Society of Obstetrics and Gynecology. Guideline for Gynecological practice (in Japanese). Tokyo: Japan Society of Obstetrics and Gynecology; 2023.
5. Mito A, Murashima A, Wada Y, Miyasato-Isoda M, Kamiya CA, Waguri M, et al. Safety of amlodipine in early pregnancy. J Am Heart Assoc. 2019;8:e012093.